HEADER TRANSFERASE 28-NOV-17 6BQQ TITLE CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH BI2526 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 161-449; COMPND 5 SYNONYM: CAMKK 2,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE COMPND 6 BETA,CAMKK BETA; COMPND 7 EC: 2.7.11.17; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CAMKK2, CAMKKB, KIAA0787; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE, PROTEIN KINASE DOMAIN, STRUCTURAL GENOMICS, STRUCTURAL KEYWDS 2 GENOMICS CONSORTIUM, SGC, TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.M.COUNAGO,G.P.DE SOUZA,C.V.DOS REIS,P.Z.RAMOS,D.DREWRY, AUTHOR 2 K.B.MASSIRER,P.ARRUDA,A.M.EDWARDS,J.M.ELKINS,STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM (SGC) REVDAT 4 04-OCT-23 6BQQ 1 REMARK REVDAT 3 01-JAN-20 6BQQ 1 REMARK REVDAT 2 17-APR-19 6BQQ 1 REMARK REVDAT 1 13-DEC-17 6BQQ 0 JRNL AUTH R.M.COUNAGO,G.P.DE SOUZA,C.V.DOS REIS,D.DREWRY,K.B.MASSIRER, JRNL AUTH 2 P.ARRUDA,A.M.EDWARDS,J.M.ELKINS, JRNL AUTH 3 STRUCTURAL GENOMICS CONSORTIUM (SGC) JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH JRNL TITL 2 BI2526 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29482 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1539 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2141 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2114 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.19000 REMARK 3 B22 (A**2) : -0.19000 REMARK 3 B33 (A**2) : 0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.882 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2211 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2059 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2996 ; 1.431 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4782 ; 0.947 ; 2.973 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 268 ; 5.871 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 94 ;36.791 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 373 ;11.780 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;21.237 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 336 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2416 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 408 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1084 ; 1.185 ; 1.990 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1080 ; 1.165 ; 1.981 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1346 ; 2.011 ; 2.959 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1347 ; 2.010 ; 2.961 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1126 ; 1.322 ; 2.116 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1127 ; 1.321 ; 2.118 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1651 ; 2.162 ; 3.127 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2473 ; 5.089 ;24.328 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2474 ; 5.088 ;24.349 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 159 A 448 REMARK 3 ORIGIN FOR THE GROUP (A): 15.1150 9.8120 43.9280 REMARK 3 T TENSOR REMARK 3 T11: 0.1814 T22: 0.0830 REMARK 3 T33: 0.0136 T12: 0.0199 REMARK 3 T13: -0.0075 T23: -0.0170 REMARK 3 L TENSOR REMARK 3 L11: 0.7021 L22: 0.0945 REMARK 3 L33: 0.5921 L12: 0.2006 REMARK 3 L13: 0.0593 L23: 0.1108 REMARK 3 S TENSOR REMARK 3 S11: -0.0638 S12: 0.0219 S13: -0.0346 REMARK 3 S21: -0.0196 S22: 0.0193 S23: -0.0157 REMARK 3 S31: -0.0377 S32: -0.0541 S33: 0.0445 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6BQQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000231284. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979100 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31086 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 12.80 REMARK 200 R MERGE FOR SHELL (I) : 1.15000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5UYJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG 3350; 0.21 M AMMONIUM REMARK 280 SULPHATE; 0.1M CHC BUFFER PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.64200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.76600 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.76600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.46300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.76600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.76600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.82100 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.76600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.76600 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 89.46300 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.76600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.76600 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.82100 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 59.64200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 204 REMARK 465 ALA A 205 REMARK 465 GLY A 206 REMARK 465 PHE A 207 REMARK 465 PRO A 208 REMARK 465 ARG A 209 REMARK 465 ARG A 210 REMARK 465 PRO A 211 REMARK 465 PRO A 212 REMARK 465 PRO A 213 REMARK 465 ARG A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 ARG A 217 REMARK 465 PRO A 218 REMARK 465 ALA A 219 REMARK 465 PRO A 220 REMARK 465 GLY A 221 REMARK 465 PRO A 413 REMARK 465 HIS A 449 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 199 CG CD CE NZ REMARK 470 LYS A 200 CG CD CE NZ REMARK 470 ARG A 227 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 242 CG CD CE NZ REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 LYS A 282 CG CD CE NZ REMARK 470 LYS A 338 CG CD CE NZ REMARK 470 GLU A 361 CG CD OE1 OE2 REMARK 470 ARG A 363 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 393 CG CD OE1 OE2 REMARK 470 GLU A 408 CG CD OE1 OE2 REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 ARG A 448 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 163 -122.76 51.47 REMARK 500 LYS A 168 -131.88 -129.15 REMARK 500 ASP A 312 43.66 -145.69 REMARK 500 ASP A 330 81.13 63.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R78 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 504 DBREF 6BQQ A 161 449 UNP Q96RR4 KKCC2_HUMAN 161 449 SEQADV 6BQQ SER A 159 UNP Q96RR4 EXPRESSION TAG SEQADV 6BQQ MET A 160 UNP Q96RR4 EXPRESSION TAG SEQRES 1 A 291 SER MET GLN LEU ASN GLN TYR THR LEU LYS ASP GLU ILE SEQRES 2 A 291 GLY LYS GLY SER TYR GLY VAL VAL LYS LEU ALA TYR ASN SEQRES 3 A 291 GLU ASN ASP ASN THR TYR TYR ALA MET LYS VAL LEU SER SEQRES 4 A 291 LYS LYS LYS LEU ILE ARG GLN ALA GLY PHE PRO ARG ARG SEQRES 5 A 291 PRO PRO PRO ARG GLY THR ARG PRO ALA PRO GLY GLY CYS SEQRES 6 A 291 ILE GLN PRO ARG GLY PRO ILE GLU GLN VAL TYR GLN GLU SEQRES 7 A 291 ILE ALA ILE LEU LYS LYS LEU ASP HIS PRO ASN VAL VAL SEQRES 8 A 291 LYS LEU VAL GLU VAL LEU ASP ASP PRO ASN GLU ASP HIS SEQRES 9 A 291 LEU TYR MET VAL PHE GLU LEU VAL ASN GLN GLY PRO VAL SEQRES 10 A 291 MET GLU VAL PRO THR LEU LYS PRO LEU SER GLU ASP GLN SEQRES 11 A 291 ALA ARG PHE TYR PHE GLN ASP LEU ILE LYS GLY ILE GLU SEQRES 12 A 291 TYR LEU HIS TYR GLN LYS ILE ILE HIS ARG ASP ILE LYS SEQRES 13 A 291 PRO SER ASN LEU LEU VAL GLY GLU ASP GLY HIS ILE LYS SEQRES 14 A 291 ILE ALA ASP PHE GLY VAL SER ASN GLU PHE LYS GLY SER SEQRES 15 A 291 ASP ALA LEU LEU SER ASN THR VAL GLY THR PRO ALA PHE SEQRES 16 A 291 MET ALA PRO GLU SER LEU SER GLU THR ARG LYS ILE PHE SEQRES 17 A 291 SER GLY LYS ALA LEU ASP VAL TRP ALA MET GLY VAL THR SEQRES 18 A 291 LEU TYR CYS PHE VAL PHE GLY GLN CYS PRO PHE MET ASP SEQRES 19 A 291 GLU ARG ILE MET CYS LEU HIS SER LYS ILE LYS SER GLN SEQRES 20 A 291 ALA LEU GLU PHE PRO ASP GLN PRO ASP ILE ALA GLU ASP SEQRES 21 A 291 LEU LYS ASP LEU ILE THR ARG MET LEU ASP LYS ASN PRO SEQRES 22 A 291 GLU SER ARG ILE VAL VAL PRO GLU ILE LYS LEU HIS PRO SEQRES 23 A 291 TRP VAL THR ARG HIS HET R78 A 501 38 HET ACT A 502 4 HET ACT A 503 4 HET ACT A 504 4 HETNAM R78 4-{[(7R)-8-CYCLOPENTYL-7-ETHYL-5-METHYL-6-OXO-5,6,7,8- HETNAM 2 R78 TETRAHYDROPTERIDIN-2-YL]AMINO}-3-METHOXY-N-(1- HETNAM 3 R78 METHYLPIPERIDIN-4-YL)BENZAMIDE HETNAM ACT ACETATE ION FORMUL 2 R78 C28 H39 N7 O3 FORMUL 3 ACT 3(C2 H3 O2 1-) FORMUL 6 HOH *180(H2 O) HELIX 1 AA1 LYS A 198 ARG A 203 1 6 HELIX 2 AA2 GLY A 228 LYS A 242 1 15 HELIX 3 AA3 SER A 285 GLN A 306 1 22 HELIX 4 AA4 LYS A 314 SER A 316 5 3 HELIX 5 AA5 THR A 350 MET A 354 5 5 HELIX 6 AA6 ALA A 355 LEU A 359 5 5 HELIX 7 AA7 GLY A 368 GLY A 386 1 19 HELIX 8 AA8 ARG A 394 GLN A 405 1 12 HELIX 9 AA9 ALA A 416 LEU A 427 1 12 HELIX 10 AB1 VAL A 436 LEU A 442 1 7 HELIX 11 AB2 HIS A 443 ARG A 448 1 6 SHEET 1 AA1 6 MET A 160 LEU A 162 0 SHEET 2 AA1 6 TYR A 165 GLY A 174 -1 O LEU A 167 N MET A 160 SHEET 3 AA1 6 GLY A 177 ASN A 184 -1 O LEU A 181 N LYS A 168 SHEET 4 AA1 6 THR A 189 SER A 197 -1 O VAL A 195 N VAL A 178 SHEET 5 AA1 6 HIS A 262 GLU A 268 -1 O PHE A 267 N ALA A 192 SHEET 6 AA1 6 LEU A 251 LEU A 255 -1 N VAL A 252 O VAL A 266 SHEET 1 AA2 2 ILE A 308 ILE A 309 0 SHEET 2 AA2 2 ASN A 335 GLU A 336 -1 O ASN A 335 N ILE A 309 SHEET 1 AA3 2 LEU A 318 VAL A 320 0 SHEET 2 AA3 2 ILE A 326 ILE A 328 -1 O LYS A 327 N LEU A 319 SHEET 1 AA4 2 LEU A 343 LEU A 344 0 SHEET 2 AA4 2 PHE A 366 SER A 367 -1 O PHE A 366 N LEU A 344 SSBOND 1 CYS A 223 CYS A 397 1555 7556 2.08 CISPEP 1 VAL A 278 PRO A 279 0 -1.96 SITE 1 AC1 11 ILE A 171 VAL A 179 VAL A 249 PHE A 267 SITE 2 AC1 11 GLU A 268 LEU A 269 VAL A 270 ASN A 271 SITE 3 AC1 11 LEU A 319 LYS A 338 HOH A 659 SITE 1 AC2 4 SER A 159 LYS A 168 ASP A 169 HOH A 644 SITE 1 AC3 6 GLN A 272 ARG A 311 ASN A 335 LEU A 344 SITE 2 AC3 6 SER A 345 ASN A 346 SITE 1 AC4 3 ASP A 169 TYR A 190 ILE A 365 CRYST1 73.532 73.532 119.284 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013600 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013600 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008383 0.00000